Aug. 11 at 11:47 AM
Needham⬆️
$AXSM's PT to
$268 from
$267, reit'd Buy and said -- AXSM traded up ~4% following the 2Q earnings report, with Auvelity continuing to grow nicely in MDD benefiting from the sales force expansion in 2Q and improved coverage.
$OTSKY $ACAD BMY
Wells Fargo⬆️ Axsome Therapeutics' PT to
$256 from
$255, reit'd Overweight and said -- Uptake of Auvelity in AD Agitation is in its infancy, but mgmt commentary is encouraging.
Here's what Needham and Wells Fargo went on to say: https://x.com/Quantumup1/status/2087143502622736817?s=20
